TMCnet News

Technavio Expects the Global Molecular Diagnostics Market to Reach USD 11 Billion by 2020
[April 27, 2016]

Technavio Expects the Global Molecular Diagnostics Market to Reach USD 11 Billion by 2020


According to the latest market research study released by Technavio, the global molecular diagnostics market is expected to reach USD 11 billion by 2020, growing at a CAGR of over 10% during the forecast period.

This research report titled 'Global Molecular Diagnostics Market 2016-2020', provides an in-depth analysis of the market in terms of revenue and emerging market trends. This market research report also includes an up to date analysis and forecast for various market segments and all geographical regions.

Request sample report: http://goo.gl/aiUXOh

The report segments the global molecular diagnostics market by application and can be divided into five broad segments:

  • Infectious disease testing
  • Oncological testing
  • Blood testing
  • Genetic testing
  • Tissue typing

Global molecular diagnostics market by infectious disease testing

The global molecular diagnostics market by infectious disease testing is likely to exceed USD 4.8 billion by 2020, growing at a CAGR of over 11%.

Molecular diagnostic techniques such as PCR (News - Alert), DNA sequencing, mass spectrometry, and next-generation sequencing (NGS) are the most commonly used techniques in the diagnosis of diseases. These tests are accurate, sensitive, and help in understanding and detecting the activity of various infectious agents, which can help in the management of diseases at an early stage.

According to Barath Palada, lead analyst at Technavio for oncology research, "The emergence and re-emergence of multidrug resistant strains of microorganisms, new strains of HIV and H1N1, development of new technologies, and shift in the testing environment from laboratory to point-of-care settings are factors that will help in the growth of the market."

Global molecular diagnostics market by oncological testing

The global molecular diagnostics market by oncological testing is likely to exceed USD 2.6 billion by 2020, growing at a CAGR of over 13%.

Molecular diagnostics not only acts as an early detection tool, but also as a disease management tool. In addition, use of diagnostic biomarkers (IGH gene clonality assay) and prognostic biomarkers (FLT3 mutation test) fr determining prognosis or for long-term monitoring of an already diagnosed disease enhances treatment and prognosis compared to traditional methods.



The market is expected to witness maximum growth during the forecast period because of a rise in the number of cancer patients worldwide, wide area of applications, increase in regulatory approvals for products, shift toward treatment of root causes, and focus on development of companion diagnostics.

Global molecular diagnostics market by blood testing


The global molecular diagnostics market by blood testing is expected to reach USD 1.4 billion by 2020, growing at a CAGR of over 7%.

Blood screening or testing is a process in which blood is analyzed for the presence of particular disease causing agents. The blood screenings are performed to detect infections, pregnancies, blood types, and cancers.

The use of blood screening in various fields, such as oncology, and the launch of cost-effective tests will contribute to market growth. Also, the development and launch of new blood screening tests is paving the way for the growth of this market.

Global molecular diagnostics market by genetic testing

The global molecular diagnostics market by genetic testing is likely to exceed USD 1.3 billion by 2020, growing at a CAGR of over 8%.

Genetic testing detects changes in inheritable disorders by analyzing DNA, RNA, chromosomes, proteins, and other metabolites. This testing helps identify individuals' susceptibility to a disease and response to specific treatment, thus, creating a more personalized approach to healthcare. "The genetic testing techniques have grown from offering niche specialty solutions for rare disorders to providing solutions for a broad range of healthcare applications, creating a more personalized approach to healthcare," says Barath.

The market is experiencing an increased demand due to the fact that physicians are shifting from one-size-fits-all approach to a more personalized approach considering the fatal drug reactions caused due to genetic variability.

Global molecular diagnostics market by tissue typing

The global molecular diagnostics market by tissue typing is likely to reach USD 639 million by 2020, growing at a CAGR of over 5%.

Tissue typing are tests that assess the compatibility between donors and recipients in organ transplant procedures. These tests are called human leukocyte antigen (HLA) tests as they work on the principle of recognizing self and non-self antigens present in the body.

A rise in the number of patients with organ failures and increase in R&D with focus on developing new treatment strategies and technologies is supplementing market growth.

Technavio's healthcare and life sciences research analysts highlight the following four vendors as the top contributors to the global molecular diagnostics market:

  • Abbott Diagnostics
  • Hologic
  • Qiagen
  • Siemens (News - Alert) Healthcare

Browse Related Reports:

Purchase these three reports for the price of one by becoming a Technavio subscriber. Subscribing to Technavio's reports allows you to download any three reports per month for the price of one. Contact [email protected] with your requirements and a link to our subscription platform.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.

If you are interested in more information, please contact our media team at [email protected].


[ Back To TMCnet.com's Homepage ]